Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02077881 |
Title | Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | NewLink Genetics Corporation |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford University | Palo Alto | California | 94304 | United States | Details | |
Augusta University | Augusta | Georgia | 30912 | United States | Details | |
University of Kentucy | Lexington | Kentucky | 40536 | United States | Details | |
Washington University in St. Louis | Saint Louis | Missouri | 63110 | United States | Details | |
The Vally Hospital | Paramus | New Jersey | 07652 | United States | Details | |
University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
Greenville Health Systems | Greenville | South Carolina | 29605 | United States | Details | |
Gibbs Cancer Center and Research Institute | Spartanburg | South Carolina | 29303 | United States | Details | |
The West Clinic | Memphis | Tennessee | 38120 | United States | Details | |
Huntsman Cancer Center | Salt Lake City | Utah | 84112 | United States | Details | |
University of Vermont Medical Center | Burlington | Vermont | 05401 | United States | Details |